 The purpose of this study is to determine if acetyl-L-carnitine ALC reduces pain, numbness, and tingling in the feet and legs of patients with nucleoside reverse transcriptase inhibitor NRTI-associated peripheral neuropathy. Another purpose is to determine if ALC is safe and tolerable in HIV patients who have taken certain anti-HIV drugs. 